Annoucements

ISTH Academy, Faculty / Presenters, 4142498

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series

ISTH Academy, Agnes Lee, 4147740

Is lupus anticoagulant testing with dilute Russell’s viper venom clotting times reliable in the presence of inflammation?

ISTH Academy, Faculty / Presenters, 4147739

Predictors of diagnostic delays and loss to follow-up in women with von Willebrand disease: a single-center retrospective cohort study

ISTH Academy, , 4147738

Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices

ISTH Academy, , 4147737

Proportion and risk factors for hospital-acquired venous thromboembolism in children: a systematic review and meta-analysis of data from 20 million individuals in 22 countries

ISTH Academy, Jinhua Zhang, 4147736

A single-center study of patients with rare isolated acquired clotting factor deficiencies other than acquired hemophilia A

ISTH Academy, Lei Zhang, 4147735

Plant-derived compounds normalize platelet bioenergetics and function in hyperglycemia

ISTH Academy, , 4147734

Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk

ISTH Academy, Faculty / Presenters, 4147733

Antipolyphosphate monoclonal antibodies derived from autoimmune mice

ISTH Academy, James Morrissey, 4147732

Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid

ISTH Academy, Faculty / Presenters, 4147731

Intensive care treatment in acute pulmonary embolism in Germany, 2016 to 2020: a nationwide inpatient database study

ISTH Academy, Faculty / Presenters, 4147730

Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation

ISTH Academy, Faculty / Presenters, 4147729

Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisons

ISTH Academy, Faculty / Presenters, 4147728

Can hemophilia be cured? It depends on the definition

ISTH Academy, , 4147727

The risk of venous thromboembolism in primary central nervous system lymphoma: a systematic review and meta-analysis

ISTH Academy, , 4147726

MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches

ISTH Academy, , 4147725

Comprehensive literature review of protein C concentrate use in patients with severe congenital protein C deficiency

ISTH Academy, Faculty / Presenters, 4147724

G protein–coupled receptor kinase 5 regulates thrombin signaling in platelets

ISTH Academy, Craig Morrell, 4147741

Corrigendum to ‘Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand’

ISTH Academy, Steve Watson, 4142497

Obituary Professor Margareta “Meta” Blombäck (1925-2024)

ISTH Academy, Faculty / Presenters, 4142496

“Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome”: reply

ISTH Academy, Faculty / Presenters, 4142495

“Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for antiphospholipid syndrome”: comment

ISTH Academy, Armando Tripodi, 4142494

“Prothrombin conversion and thrombin decay in patients with cirrhosis—role of prothrombin and antithrombin deficiencies”: comment

ISTH Academy, Thomas Lecompte, 4142493

New Insights in Diagnosis and Treatment of Antiphospholipid Syndrome

ISTH Academy, Faculty / Presenters, 4139869

Application of machine learning approaches for predicting hemophilia A severity

ISTH Academy, Zuben Sauna, 4140571

Role of microbiota-derived corisin in coagulation activation during SARS-CoV-2 infection

ISTH Academy, Faculty / Presenters, 4140572

Diagnosis of thrombotic thrombocytopenic purpura: easy-to-use fiber optic surface plasmon resonance immunoassays for automated ADAMTS-13 antigen and conformation evaluation

ISTH Academy, Karen Vanhoorelbeke, 4140573

Disparities in access to and timing of interventional therapies for pulmonary embolism across the United States

ISTH Academy, Faculty / Presenters, 4140574

Microtubule interacting and trafficking domain containing 1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer

ISTH Academy, , 4140575

Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey

ISTH Academy, Faculty / Presenters, 4140576

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia

ISTH Academy, Radhika Gangaraju, 4140577

A deep-learning approach to predict bleeding risk over time in patients on extended anticoagulation therapy

ISTH Academy, Phil S. Wells, 4140578

Myosin light chain 6 (Myl6) interacts with kindlin-3 and is required to support integrin αβ activation in platelets in mice

ISTH Academy, Yan-Qing Ma, 4140579

Hydroxychloroquine inhibits hemolysis-induced arterial thrombosis ex vivo and improves lung perfusion in hemin-treated mice

ISTH Academy, Julie Rayes, 4140580

Transcriptional and functional profiling identifies inflammation and endothelial-to-mesenchymal transition as potential drivers for phenotypic heterogeneity within a cohort of endothelial colony forming cells

ISTH Academy, Jeroen Eikenboom, 4140581

An orthosteric/allosteric bivalent peptide agonist comprising covalently linked protease-activated receptor-derived peptides mimics in vitro and in vivo activities of activated protein C

ISTH Academy, John Griffin, 4140582

Nanobody activator improves sensitivity of the von Willebrand factor activity assay to multimer size

ISTH Academy, Renhao Li, 4140583

Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH

ISTH Academy, Faculty / Presenters, 4140584

A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

ISTH Academy, Jeffrey Zwicker, 4140585

Evaluation, analysis, and reporting of medication adherence for clinical trials of anticoagulants in children: guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis

ISTH Academy, Faculty / Presenters, 4140586

“Finding a common definition of heparin resistance in adult cardiac surgery: Communication from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis”: comment from Boissier et al.

ISTH Academy, , 4140587

“Finding a common definition of heparin resistance in adult cardiac surgery: Communication from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis”: comment from Mansour et al.

ISTH Academy, Faculty / Presenters, 4140588

“Finding a common definition of heparin resistance in adult cardiac surgery: Communication from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis”: reply

ISTH Academy, Jerrold Levy, 4140589

Annoucements

ISTH Academy, Faculty / Presenters, 4140590

Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

ISTH Academy, Faculty / Presenters, 4140569

The proteasome inhibitor carfilzomib exerts anti-inflammatory and antithrombotic effects on the endothelium

ISTH Academy, Tom McKinnon, 4140568

Multicenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A

ISTH Academy, , 4140567

The effect of administering preprocedural VITamin K on the international normalized ratio in patients anticoagulated with ACEnocoumarol (VITKACE-study): a prospective cohort study

ISTH Academy, Remy Bemelmans, 4140566

Ultra-Long factor VIII: a major step forward toward a hemophilia-free mind

ISTH Academy, Faculty / Presenters, 4140565

Time to simplify perioperative management of vitamin K antagonists

ISTH Academy, Daniel Witt, 4140564

Navigating the inevitable: artificial intelligence and the future of scientific communication

ISTH Academy, , 4145764

Bleeding in valvular heart disease: is von Willebrand factor the culprit?

ISTH Academy, Sophie Susen, 4145765

Syndemics in women’s health: poverty, social exclusion, and clustering of thrombotic and hemostasis disorders

ISTH Academy, , 4145766

Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus

ISTH Academy, , 4145767

Quality of life in oncological patients with venous thromboembolic disease

ISTH Academy, Cristhiam Mauricio Rojas Hernandez, 4145768

Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis

ISTH Academy, Faculty / Presenters, 4145769

Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods

ISTH Academy, Faculty / Presenters, 4145770

Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany

ISTH Academy, Faculty / Presenters, 4145771

Modeling cancer-associated hypercoagulability using glioblastoma spheroids in microfluidic chips

ISTH Academy, Araci Rondon, 4145772

Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies

ISTH Academy, , 4145773

Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis

ISTH Academy, Faculty / Presenters, 4145774

The association between unemployment and treatment among adults with hemophilia

ISTH Academy, Faculty / Presenters, 4145775

Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study

ISTH Academy, Faculty / Presenters, 4145776

Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura

ISTH Academy, Faculty / Presenters, 4145777

Serum albumin, genetic susceptibility, and risk of venous thromboembolism

ISTH Academy, Yu Hu, 4145778

A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage

ISTH Academy, Faculty / Presenters, 4145779

Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study

ISTH Academy, Kochawan Boonyawat, 4145780

A comparative study of anti–ADAMTS-13 antibody dynamics in immune-mediated thrombotic thrombocytopenic purpura

ISTH Academy, Faculty / Presenters, 4145781

Multiparameter phenotyping of platelets and characterization of the effects of agonists using machine learning

ISTH Academy, , 4145782

The association of antiplatelet agents with mortality among patients with non–COVID-19 community-acquired pneumonia: a systematic review and meta-analysis

ISTH Academy, , 4145783

Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial

ISTH Academy, Stefano Barco, 4145784

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy

ISTH Academy, Masanori Matsumoto, 4145785

Electronic consultation to improve care outcomes in patients with suspected and confirmed heparin-induced thrombocytopenia

ISTH Academy, Faculty / Presenters, 4145786

Ascertaining accurate exposure to aspirin and other antithrombotic medications using structured electronic health record data

ISTH Academy, Faculty / Presenters, 4145787

Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial

ISTH Academy, Faculty / Presenters, 4145788

In vitro assessment of the risk of ABCB1-mediated drug–drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines

ISTH Academy, Laure Elens, 4145789

Transmembrane thiol isomerase TMX1 counterbalances the effect of ERp46 to inhibit platelet activation and integrin αIIbβ3 function

ISTH Academy, Yi Wu, 4145790

Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk

ISTH Academy, Faculty / Presenters, 4145791

Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial

ISTH Academy, Faculty / Presenters, 4145792

Managing surgical relapse risk in acquired thrombotic thrombocytopenic purpura: a systematic review

ISTH Academy, , 4145793

A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology

ISTH Academy, Hubert GALINAT, 4145794

A hard look in the mirror: disparities in reperfusion therapy for acute pulmonary embolism in the United States and failure to reduce mortality

ISTH Academy, Gregory Piazza, 4140563

Microbiota-driven coagulation activation during SARS-CoV-2 infection

ISTH Academy, Silvio Antoniak, 4140562

Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?

ISTH Academy, Faculty / Presenters, 4140561

Management of abnormal uterine bleeding on anticoagulation: the patient–clinician perspective

ISTH Academy, Bethany Samuelson Bannow, 4140560

Recent advances in vascular thiol isomerases and redox systems in platelet function and thrombosis

ISTH Academy, Faculty / Presenters, 4140559

Removing cross-cultural barriers to participation in the ISTH Congress

ISTH Academy, Alan Harper, 4140558

Issue Information

ISTH Academy, Faculty / Presenters, 4140557

Variant mapping using mass spectrometry–based proteotyping as a diagnostic tool in von Willebrand disease

ISTH Academy, Maartje van den Biggelaar, 4140570

Efficacy and Safety of Prophylaxis with a Plasma-derived von Willebrand Factor/Factor VIII Concentrate in Type 3 Patients with von Willebrand Disease – A Sub-Analysis of Data from the WIL-31 Study

ISTH Academy, Robert Sidonio, 4137668

Citrullination of TFPI impairs its natural anticoagulant activity towards factors Xa, VIIa and tissue factor, and reduces binding of its cofactor protein S.

ISTH Academy, Bryan Bouwens, 4137754

Three-Year Efficacy Assessment of Emicizumab in Hemophilia A Patients without Inhibitors: A Tailored Dose Titration Approach

ISTH Academy, Maria Galí Sampalo, 4137753

Effect of Steroid Use on Incidence of Pulmonary Embolism in patients with COPD: Korean Nationwide Cohort Study

ISTH Academy, Hun-Gyu Hwang, 4137662

Light Transmission Aggregation data from the United Kingdom National External Quality assessment for Blood Coagulation programme 2023.

ISTH Academy, Christopher Reilly-Stitt, 4137658

VGA039, a Protein S-targeting monoclonal antibody, demonstrates in a Phase Ia healthy volunteer trial the potential of subcutaneous weekly or less frequent prophylactic dosing for bleeding disorders

ISTH Academy, Christian Schoergenhofer, 4137421

Computable phENotype To Identify Pulmonary Embolism in chilDrEn: The CENTIPEDE study

ISTH Academy, Hilary Whitworth, 4137652

Fitusiran displays efficient pro-hemostatic activity in a mouse model of inducible factor X-deficiency

ISTH Academy, Genevieve McCluskey, 4137648

Ultrasound-accelerated catheter-directed thrombolysis, effects on patency and reflux in relation to post-thrombotic syndrome: a subanalysis of the CAVA trial.

ISTH Academy, Ruben Hupperetz, 4137645

A ten-year experience of high-risk pulmonary embolism in a tertiary center

ISTH Academy, Andreas Verstraete, 4137415